BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19403004)

  • 1. Molecular mechanisms of psychostimulant addiction.
    Chen JC; Chen PC; Chiang YC
    Chang Gung Med J; 2009; 32(2):148-54. PubMed ID: 19403004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats.
    Chiang YC; Chen JC
    J Neurochem; 2007 Dec; 103(6):2505-17. PubMed ID: 17953657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization.
    Chen PC; Lao CL; Chen JC
    J Neurochem; 2007 Jan; 100(1):225-41. PubMed ID: 17101033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKA-mediated responses in females' estrous cycle affect cocaine-induced responses in dopamine-mediated intracellular cascades.
    Weiner J; Sun WL; Zhou L; Kreiter CM; Jenab S; Quiñones-Jenab V
    Neuroscience; 2009 Jul; 161(3):865-76. PubMed ID: 19348873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system.
    Self DW
    Neuropharmacology; 2004; 47 Suppl 1():242-55. PubMed ID: 15464141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine and ethanol activate protein kinase A synergistically via G(i) betagamma subunits in nucleus accumbens/ventral tegmental cocultures: the role of dopamine D(1)/D(2) and adenosine A(2A) receptors.
    Inoue Y; Yao L; Hopf FW; Fan P; Jiang Z; Bonci A; Diamond I
    J Pharmacol Exp Ther; 2007 Jul; 322(1):23-9. PubMed ID: 17468300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent anatomical pattern of D1 and D3 binding and dopamine- and cyclic AMP-regulated phosphoprotein of 32 kDa mRNA expression in the Roman rat strains: Implications for drug addiction.
    Guitart-Masip M; Johansson B; Fernández-Teruel A; Cañete T; Tobeña A; Terenius L; Giménez-Llort L
    Neuroscience; 2006 Nov; 142(4):1231-43. PubMed ID: 17008016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drug actions on gene modulation and signaling mechanisms.
    Molteni R; Calabrese F; Racagni G; Fumagalli F; Riva MA
    Pharmacol Ther; 2009 Oct; 124(1):74-85. PubMed ID: 19540875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and cyclic AMP-regulated phosphoprotein-32 phosphorylation pattern in cocaine and morphine-sensitized rats.
    Scheggi S; Rauggi R; Gambarana C; Tagliamonte A; De Montis MG
    J Neurochem; 2004 Aug; 90(4):792-9. PubMed ID: 15287884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alteration of neuronal activities following repeated administration of stimulants].
    Amano T; Matsubayashi H; Sasa M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2002 Feb; 37(1):31-40. PubMed ID: 11915303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine-induced sensitization differentially alters pCREB and DeltaFosB throughout the limbic circuit of the mammalian brain.
    McDaid J; Graham MP; Napier TC
    Mol Pharmacol; 2006 Dec; 70(6):2064-74. PubMed ID: 16951039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action.
    Hummel M; Unterwald EM
    J Cell Physiol; 2002 Apr; 191(1):17-27. PubMed ID: 11920678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin releasing factor and neuroplasticity in cocaine addiction.
    Corominas M; Roncero C; Casas M
    Life Sci; 2010 Jan; 86(1-2):1-9. PubMed ID: 19914260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference.
    Herrold AA; Shen F; Graham MP; Harper LK; Specio SE; Tedford CE; Napier TC
    Drug Alcohol Depend; 2009 Jan; 99(1-3):231-9. PubMed ID: 18945553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of dopamine D₂ receptors in the nucleus accumbens core suppresses methamphetamine-induced behaviors and signal transduction in mice.
    Miyamoto Y; Iida A; Sato K; Muramatsu S; Nitta A
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of drug addiction.
    Nestler EJ
    Neuropharmacology; 2004; 47 Suppl 1():24-32. PubMed ID: 15464123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Involvement of prefrontal serotonergic neurons in methamphetamine-induced behavioral sensitization].
    Ago Y; Nakamura S; Arikawa S; Yata M; Matsuda T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Apr; 28(2):85-91. PubMed ID: 18516987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DARPP-32 and modulation of cAMP signaling: involvement in motor control and levodopa-induced dyskinesia.
    Håkansson K; Lindskog M; Pozzi L; Usiello A; Fisone G
    Parkinsonism Relat Disord; 2004 Jul; 10(5):281-6. PubMed ID: 15196506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of development of behavioral sensitization to methylphenidate in mice: correlation with reversible astrocytic activation.
    Suzuki T; Shindo K; Miyatake M; Kurokawa K; Higashiyama K; Suzuki M; Narita M
    Eur J Pharmacol; 2007 Nov; 574(1):39-48. PubMed ID: 17869241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular biology of drug dependence and behavioral sensitization].
    Ujike H
    Seishin Shinkeigaku Zasshi; 2002; 104(11):1055-68. PubMed ID: 12642909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.